Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;52(4):e12604.
doi: 10.1111/cpr.12604. Epub 2019 May 8.

Effect of inoculum density on human-induced pluripotent stem cell expansion in 3D bioreactors

Affiliations

Effect of inoculum density on human-induced pluripotent stem cell expansion in 3D bioreactors

Selina Greuel et al. Cell Prolif. 2019 Jul.

Abstract

Objective: For optimized expansion of human-induced pluripotent stem cells (hiPSCs) with regards to clinical applications, we investigated the influence of the inoculum density on the expansion procedure in 3D hollow-fibre bioreactors.

Materials and methods: Analytical-scale bioreactors with a cell compartment volume of 3 mL or a large-scale bioreactor with a cell compartment volume of 17 mL were used and inoculated with either 10 × 106 or 50 × 106 hiPSCs. Cells were cultured in bioreactors over 15 days; daily measurements of biochemical parameters were performed. At the end of the experiment, the CellTiter-Blue® Assay was used for culture activity evaluation and cell quantification. Also, cell compartment sections were removed for gene expression and immunohistochemistry analysis.

Results: The results revealed significantly higher values for cell metabolism, cell activity and cell yields when using the higher inoculation number, but also a more distinct differentiation. As large inoculation numbers require cost and time-extensive pre-expansion, low inoculation numbers may be used preferably for long-term expansion of hiPSCs. Expansion of hiPSCs in the large-scale bioreactor led to a successful production of 5.4 × 109 hiPSCs, thereby achieving sufficient cell amounts for clinical applications.

Conclusions: In conclusion, the results show a significant effect of the inoculum density on cell expansion, differentiation and production of hiPSCs, emphasizing the importance of the inoculum density for downstream applications of hiPSCs. Furthermore, the bioreactor technology was successfully applied for controlled and scalable production of hiPSCs for clinical use.

Keywords: 3D culture; bioreactor culture; cell expansion; human-induced pluripotent stem cells; inoculum density.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

Figure 1
Figure 1
Bioreactor types used for the expansion of hiPSCs with their capillary structure. The picture shows the analytical‐scale bioreactor (A) with a cell compartment volume of 3 mL and the large‐scale bioreactor (B) with a cell compartment volume of 17 mL. The schematic image on top shows a section of the capillary structure inside the bioreactor, consisting of the following four compartments: medium capillaries I (red) and II (blue) for countercurrent medium perfusion, gas capillaries (yellow) and the space surrounding the capillaries, which serves as the cell compartment (white). The scale bars correspond to 2 cm
Figure 2
Figure 2
Comparison of clinical chemistry parameters during the culture of human‐induced pluripotent stem cells over 15 days in analytical‐scale bioreactors inoculated with either 10 × 106 (AS 10, n = 4) or 50 × 106 (AS 50, n = 3) cells, or the large‐scale bioreactor inoculated with 50 × 106 (LS 50, n = 1) cells. Values are presented as mean ± SEM (AS 10 and AS 50) or single values (LS 50). The two analytical‐scale bioreactors were compared by means of the areas under the curves (AUCs) and the tipping points (TP). Differences were considered significant at P < 0.05
Figure 3
Figure 3
Gene expression analysis after 15 days of hiPSC culture in analytical‐scale bioreactors inoculated with 10 × 106 (AS 10) or 50 × 106 (AS 50) cells, in the large‐scale bioreactor inoculated with 50 × 106 cells (LS 50), on 2D culture plates, or after formation of embryoid bodies. The figure displays gene expression data of POU Class 5 Homeobox 1 (POU5F1, [A]), Nanog Homeobox (NANOG, [B]), Alpha‐Fetoprotein (AFP, [C]), SRY‐Box 17 (SOX17, [D]), C‐X‐C Motif Chemokine Receptor 4 (CXCR4, [E]), Paired Box 6 (PAX6, [F]), Neurofilament Light (NEFL, [G]), GATA Binding Protein 2 (GATA2, [H]) and T‐Box Transcription Factor T (T, [I]). Expression data were normalized to the housekeeping gene Glyceraldehyde‐3‐Phosphate Dehydrogenase (GAPDH), and n‐fold expression values were calculated relative to undifferentiated hiPSCs before inoculation on d0 using the ΔΔC t method. Data are presented as mean ± SEM (AS 10 n = 3; AS 50 n = 3; LS 50 n = 1; 2D d15 n = 5; EB's d15 n = 3). Differences between AS 10, AS 50 as well as 2D cultures and embryoid bodies were detected using the one‐way ANOVA; calculated values were considered significant at *P < 0.05, **P < 0.01 and ***P < 0.001
Figure 4
Figure 4
Comparison of CellTiter‐Blue® fluorescence values over a time period of up to 60 minutes on the final day of the experiment (day 15). The figure shows measurements performed in analytical‐scale bioreactors (AS) inoculated with 10 × 106 (AS 10, n = 2) or 50 × 106 (AS 50, n = 3) cells, the large‐scale bioreactor (LS) inoculated with 50 × 106 cells (LS 50, n = 1) and 2D cultures (2D d15, n = 4). Differences in the gradients of the corresponding linear correlation were detected using the unpaired, two‐tailed Student's t test and considered statistically significant at *P < 0.05 and **P < 0.01
Figure 5
Figure 5
Immunohistochemical staining of undifferentiated human‐induced pluripotent stem cells (hiPSCs) and hiPSCs after culture in analytical‐scale bioreactors (AS) inoculated with 10 × 106 cells (AS 10) or 50 × 106 cells (AS 50), in the large‐scale bioreactor (LS) inoculated with 50 × 106 cells (LS 50) and in embryoid bodies (EB's d 15). The figure shows staining of POU Class 5 Homeobox 1 (POU5F1, A‐E), marker of proliferation (MKI67, F‐J), α‐smooth muscle actin (α‐SMA, K‐O) and vimentin (VIM, P‐T), alpha‐fetoprotein (AFP, U‐Y) and nestin (NES, Z‐AD). Nuclei were counterstained with Dapi (blue). Scale bars correspond to 100 µm

Similar articles

Cited by

References

    1. Schwartz SD, Regillo CD, Lam BL, et al. Human embryonic stem cell‐derived retinal pigment epithelium in patients with age‐related macular degeneration and Stargardt's macular dystrophy: follow‐up of two open‐label phase 1/2 studies. Lancet. 2015;385(9967):509‐516. 10.1016/S0140-6736(14)61376-3 - DOI - PubMed
    1. Robinton DA, Daley GQ. The promise of induced pluripotent stem cells in research and therapy. Nature. 2012;481(7381):295‐305. 10.1038/nature10761 - DOI - PMC - PubMed
    1. Centeno E, Cimarosti H, Bithell A. 2D versus 3D human induced pluripotent stem cell‐derived cultures for neurodegenerative disease modelling. Mol Neurodegener. 2018;13(1):27 10.1186/s13024-018-0258-4 - DOI - PMC - PubMed
    1. Di Baldassarre A, Cimetta E, Bollini S, Gaggi G, Ghinassi B. Human‐induced pluripotent stem cell technology and cardiomyocyte generation: progress and clinical applications. Cells. 2018;7(6):E48 10.3390/cells7060048 - DOI - PMC - PubMed
    1. Mondragon‐Gonzalez R, Perlingeiro R. Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery. Dis Model Mech. 2018;11(7):dmm034728 10.1242/dmm.034728 - DOI - PMC - PubMed